Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS

Table 1

Clinical features and baseline laboratory data.

	HD patients	Controls
Number of patients	54	57
Gender (Male/Female)	29/25	38/21
Age (years)	67 ± 14	35 ± 15
HFE genotype
wt/wt (𝑛)	35	—
H63D/wt (𝑛)	14	—
C282Y/wt (𝑛)	2	—
Hemoglobin (g/dL)	11.4 ± 1.0	14.4 ± 1.2
Iron (𝜇g/dL)	45.2 (43.1−60.0)	96.4 (89.1–104.2)
Transferrin Saturation (%)	20.5 ± 8.3	28.9 ± 9.0
Ferritin (ng/mL)	174 (156−258)	90 (47−149)
CRP (mg/dL)	4.7 (5.0−8.9)	0.8 (0.4−1.4)
Interleukin-6 (pg/mL)	6.8 ± 5.8*	—

^∗Reference range in normal subjects = 0.2–3.2 pg/mL.